Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1503745334;45335;45336 chr2:178621715;178621714;178621713chr2:179486442;179486441;179486440
N2AB1339640411;40412;40413 chr2:178621715;178621714;178621713chr2:179486442;179486441;179486440
N2A1246937630;37631;37632 chr2:178621715;178621714;178621713chr2:179486442;179486441;179486440
N2B597218139;18140;18141 chr2:178621715;178621714;178621713chr2:179486442;179486441;179486440
Novex-1609718514;18515;18516 chr2:178621715;178621714;178621713chr2:179486442;179486441;179486440
Novex-2616418715;18716;18717 chr2:178621715;178621714;178621713chr2:179486442;179486441;179486440
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTT
  • RefSeq wild type template codon: GAA
  • Domain: Ig-102
  • Domain position: 7
  • Structural Position: 8
  • Q(SASA): 0.2158
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/P None None 1.0 D 0.903 0.681 0.875806401338 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.8524 likely_pathogenic 0.8833 pathogenic -2.198 Highly Destabilizing 0.999 D 0.674 neutral None None None None N
L/C 0.9457 likely_pathogenic 0.9552 pathogenic -1.448 Destabilizing 1.0 D 0.834 deleterious None None None None N
L/D 0.9969 likely_pathogenic 0.997 pathogenic -1.898 Destabilizing 1.0 D 0.901 deleterious None None None None N
L/E 0.9836 likely_pathogenic 0.9841 pathogenic -1.844 Destabilizing 1.0 D 0.897 deleterious None None None None N
L/F 0.7109 likely_pathogenic 0.7036 pathogenic -1.585 Destabilizing 1.0 D 0.727 prob.delet. D 0.704320392 None None N
L/G 0.978 likely_pathogenic 0.9832 pathogenic -2.595 Highly Destabilizing 1.0 D 0.889 deleterious None None None None N
L/H 0.9695 likely_pathogenic 0.9674 pathogenic -1.82 Destabilizing 1.0 D 0.875 deleterious D 0.79670018 None None N
L/I 0.2213 likely_benign 0.2208 benign -1.129 Destabilizing 0.999 D 0.479 neutral D 0.659255324 None None N
L/K 0.9735 likely_pathogenic 0.9735 pathogenic -1.487 Destabilizing 1.0 D 0.867 deleterious None None None None N
L/M 0.3258 likely_benign 0.3177 benign -0.855 Destabilizing 1.0 D 0.746 deleterious None None None None N
L/N 0.9813 likely_pathogenic 0.9836 pathogenic -1.388 Destabilizing 1.0 D 0.903 deleterious None None None None N
L/P 0.8818 likely_pathogenic 0.8942 pathogenic -1.458 Destabilizing 1.0 D 0.903 deleterious D 0.547201558 None None N
L/Q 0.9432 likely_pathogenic 0.9442 pathogenic -1.536 Destabilizing 1.0 D 0.897 deleterious None None None None N
L/R 0.9533 likely_pathogenic 0.9531 pathogenic -0.915 Destabilizing 1.0 D 0.89 deleterious D 0.725693872 None None N
L/S 0.9709 likely_pathogenic 0.9731 pathogenic -2.077 Highly Destabilizing 1.0 D 0.869 deleterious None None None None N
L/T 0.8472 likely_pathogenic 0.8605 pathogenic -1.898 Destabilizing 1.0 D 0.793 deleterious None None None None N
L/V 0.2932 likely_benign 0.293 benign -1.458 Destabilizing 0.999 D 0.459 neutral D 0.705044022 None None N
L/W 0.9656 likely_pathogenic 0.955 pathogenic -1.719 Destabilizing 1.0 D 0.823 deleterious None None None None N
L/Y 0.9784 likely_pathogenic 0.9754 pathogenic -1.498 Destabilizing 1.0 D 0.868 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.